Charity Accounts Intelreading the accounts so you don’t have to

DKMS FOUNDATION

Registered charity 1150056 · accounts filings on the Charity Commission register · also known as "DELETE BLOOD CANCER" (THIS IS THE NAME BY WHICH THE CHARITY WILL BE MOST COMMONLY KNOWN) AND "DKMS", DELETE BLOOD CANCER UK, DKMS BONE MARROW DONOR CENTRE · also registered in Scotland as SC046917 (OSCR)

Get email alerts for this charity

Latest income
£12.2m
Latest spending
£12.3m
Registered
2012
Accounts read
FY2024

Financial health, per its FY2024 accounts

The accounts state that unrestricted funds decreased slightly to £2,659,153 from £2,687,912 in the prior year, resulting in a net expenditure of £28,759. The charity remains dependent on funding from its principal, DKMS Group gGmbH, which has committed to continue funding main activities for at least 12 months. The trustees consider the company to be financially healthy with positive results to budget and adequate liquidity.

What the accounts disclose

Trading subsidiary: Delete Blood Cancer UK Marketing Limited
“The company’s wholly owned subsidiary, Delete Blood Cancer UK Marketing Limited, registered at Ashburnham House, Castle Row, Horticultural Place, London W4 4JQ is a dormant company.” — page 45
Per its FY2024 accounts as filed with the Charity Commission.

Accounts audited by Forvis Mazars LLP. Discloses 3 of 6 completeness components.

Structured financials (annual return, FY ending 31/12/2024)

Total income
£12.2m
Total spending
£12.3m
Cost of raising funds
£1.3m
Reserves (reported)
£2.7m
Employees
58

Reported reserves equal ~2.6 months of spending — below the median for charities its size (median 4.6 months; benchmarks).

Trustees

Trustee list from the Charity Commission register (current, not historical).

Operates in: Ireland · Scotland · Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/12/2024£12.2m£12.3m
31/12/2023£11.9m£11.5m
31/12/2022£10.6m£9.5m
31/12/2021£9.0m£8.8m
31/12/2020£8.9m£9.3m

Common questions

Is DKMS FOUNDATION financially healthy?

The accounts state that unrestricted funds decreased slightly to £2,659,153 from £2,687,912 in the prior year, resulting in a net expenditure of £28,759. The charity remains dependent on funding from its principal, DKMS Group gGmbH, which has committed to continue funding main activities for at least 12 months. The trustees consider the company to be financially healthy with positive results to budget and adequate liquidity. Its FY2024 accounts were audited by Forvis Mazars LLP.